Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1985 Jun;54(3):873–875. doi: 10.1128/jvi.54.3.873-875.1985

Effects of cobra venom factor treatment on latent feline leukemia virus infection.

E H Kraut, J L Rojko, R G Olsen, D L Tuomari
PMCID: PMC254878  PMID: 2987539

Abstract

The role of the complement system in containment of feline leukemia virus infection was studied by cobra venom factor treatment of feline leukemia virus-immune cats. One to three weeks after cobra venom factor treatment, an increase in viral antigen in marrow myelomonocytic cells and circulating immune complexes was noted. Prevention of reactivation of feline leukemia virus infection may in part depend on an intact complement system.

Full text

PDF
873

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cochrane C. G., Müller-Eberhard H. J., Aikin B. S. Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions. J Immunol. 1970 Jul;105(1):55–69. [PubMed] [Google Scholar]
  2. Day N. K., O'Reilly-Felice C., Hardy W. D., Jr, Good R. A., Witkin S. S. Circulating immune complexes associated with naturally occurring lymphosarcoma in pet cats. J Immunol. 1980 Dec;125(6):2363–2366. [PubMed] [Google Scholar]
  3. Essex M., Klein G., Snyder S. P., Harrold J. B. Correlation between humoral antibody and regression of tumours induced by feline sarcoma virus. Nature. 1971 Sep 17;233(5316):195–196. doi: 10.1038/233195a0. [DOI] [PubMed] [Google Scholar]
  4. Essex M., Sliski A., Cotter S. M., Jakowski R. R., Hardy W. D., Jr Immunosurveillance of naturally occurring feline leukemia. Science. 1975 Nov 21;190(4216):790–792. doi: 10.1126/science.173019. [DOI] [PubMed] [Google Scholar]
  5. Fischinger P. J., Blevins C. S., Nomura S. Simple, quantitative assay for both xenotropic murine leukemia and ecotropic feline leukemia viruses. J Virol. 1974 Jul;14(1):177–179. doi: 10.1128/jvi.14.1.177-179.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Grant C. K., DeBoer D. J., Essex M., Worley M. B., Higgins J. Antibodies from healthy cats exposed to feline leukemia virus lyse feline lymphoma cells slowly with cat complement. J Immunol. 1977 Aug;119(2):401–406. [PubMed] [Google Scholar]
  7. Grant C. K., Essex M., Gardner M. B., Hardy W. D., Jr Natural feline leukemia virus infection and the immune response of cats of different ages. Cancer Res. 1980 Mar;40(3):823–829. [PubMed] [Google Scholar]
  8. Hardy W. D., Jr, Hess P. W., MacEwen E. G., McClelland A. J., Zuckerman E. E., Essex M., Cotter S. M., Jarrett O. Biology of feline leukemia virus in the natural environment. Cancer Res. 1976 Feb;36(2 Pt 2):582–588. [PubMed] [Google Scholar]
  9. Hardy W. D., Jr, Hirshaut Y., Hess P. Detection of the feline leukemia virus and other mammalian oncornaviruses by immunofluorescence. Bibl Haematol. 1973;39:778–799. doi: 10.1159/000427906. [DOI] [PubMed] [Google Scholar]
  10. Hicks J. T., Ennis F. A., Kim E., Verbonitz M. The importance of an intact complement pathway in recovery from a primary viral infection: influenza in decomplemented and in C5-deficient mice. J Immunol. 1978 Oct;121(4):1437–1445. [PubMed] [Google Scholar]
  11. Hoover E. A., Mathes L. E., Rojko J. L., Schaller J. P., Olsen R. G. Modifications of the immunofluorescence assay for feline leukemia virus group-specific antigens. Am J Vet Res. 1978 Dec;39(12):1877–1880. [PubMed] [Google Scholar]
  12. Hoover E. A., Olsen R. G., Hardy W. D., Jr, Schaller J. P., Mathes L. E., Cockerell G. L. Biologic and immunologic response of cats to experimental infection with feline leukemia virus. Bibl Haematol. 1975 Oct;(43):180–183. doi: 10.1159/000399123. [DOI] [PubMed] [Google Scholar]
  13. Hoover E. A., Olsen R. G., Hardy W. D., Jr, Schaller J. P., Mathes L. E. Feline leukemia virus infection: age-related variation in response of cats to experimental infection. J Natl Cancer Inst. 1976 Aug;57(2):365–369. doi: 10.1093/jnci/57.2.365. [DOI] [PubMed] [Google Scholar]
  14. Hoover E. A., Olsen R. G., Mathes L. E., Schaller J. P. Relationship between feline leukemia virus antigen expression and viral infectivity in blood, bone marrow, and saliva of cats. Cancer Res. 1977 Oct;37(10):3707–3710. [PubMed] [Google Scholar]
  15. Kobilinsky L., Hardy W. D., Jr, Day N. K. Hypocomplementemia associated with naturally occurring lymphosarcoma in pet cats. J Immunol. 1979 Jun;122(6):2139–2142. [PubMed] [Google Scholar]
  16. Kobilinsky L., Hardy W. D., Jr, Ellis R., Witkin S. S., Day N. K. In vitro activation of feline complement by feline leukemia virus. Infect Immun. 1980 Jul;29(1):165–170. doi: 10.1128/iai.29.1.165-170.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lewis G. K., Ranken R., Goodman J. W. Complement-dependent and -independent pathways of T cell-B cell cooperation. J Immunol. 1977 May;118(5):1744–1747. [PubMed] [Google Scholar]
  18. Liu W. T., Engelman R. W., Trang L. Q., Hau K., Good R. A., Day N. K. Appearance of cytotoxic antibody to viral gp70 on feline lymphoma cells (FL-74) in cats during ex vivo immunoadsorption therapy: quantitation, characterization, and association with remission of disease and disappearance of viremia. Proc Natl Acad Sci U S A. 1984 Jun;81(11):3516–3520. doi: 10.1073/pnas.81.11.3516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Liu W. T., Good R. A., Trang L. Q., Engelman R. W., Day N. K. Remission of leukemia and loss of feline leukemia virus in cats injected with Staphylococcus protein A: association with increased circulating interferon and complement-dependent cytotoxic antibody. Proc Natl Acad Sci U S A. 1984 Oct;81(20):6471–6475. doi: 10.1073/pnas.81.20.6471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Matsuda T., Martinelli G. P., Osler A. G. Studies on immunosuppression by cobra venom factor. II. On responses to DNP-Ficoll and DNP-Polyacrylamide. J Immunol. 1978 Nov;121(5):2048–2051. [PubMed] [Google Scholar]
  21. Medof M. E., Scarborough D., Miller G. Ability of complement to release systemic lupus erythematosus immune complexes from cell receptors. Clin Exp Immunol. 1981 May;44(2):416–425. [PMC free article] [PubMed] [Google Scholar]
  22. Rickard C. G., Post J. E., Noronha F., Barr L. M. A transmissible virus-induced lymphocytic leukemia of the cat. J Natl Cancer Inst. 1969 Jun;42(6):987–1014. [PubMed] [Google Scholar]
  23. Rojko J. L., Hoover E. A., Finn B. L., Olsen R. G. Determinants of susceptibility and resistance to feline leukemia virus infection. II. Susceptibility of feline lymphocytes to productive feline leukemia virus infection. J Natl Cancer Inst. 1981 Oct;67(4):899–910. [PubMed] [Google Scholar]
  24. Rojko J. L., Hoover E. A., Mathes L. E., Hause W. R., Schaller J. P., Olsen R. G. Detection of feline leukemia virus in tissues of cats by a paraffin embedding immunofluorescence procedure. J Natl Cancer Inst. 1978 Nov;61(5):1315–1321. doi: 10.1093/jnci/61.5.1315. [DOI] [PubMed] [Google Scholar]
  25. Rojko J. L., Hoover E. A., Mathes L. E., Krakowka S., Olsen R. G. Influence of adrenal corticosteroids on the susceptibility of cats to feline leukemia virus infection. Cancer Res. 1979 Sep;39(9):3789–3791. [PubMed] [Google Scholar]
  26. Rojko J. L., Hoover E. A., Mathes L. E., Krakowka S., Olsen R. G. Influence of adrenal corticosteroids on the susceptibility of cats to feline leukemia virus infection. Cancer Res. 1979 Sep;39(9):3789–3791. [PubMed] [Google Scholar]
  27. Rojko J. L., Hoover E. A., Quackenbush S. L., Olsen R. G. Reactivation of latent feline leukaemia virus infection. Nature. 1982 Jul 22;298(5872):385–388. doi: 10.1038/298385a0. [DOI] [PubMed] [Google Scholar]
  28. Schaller J. P., Hoover E. A., Olsen R. G. Active and passive immunization of cats with inactivated feline oncornaviruses. J Natl Cancer Inst. 1977 Nov;59(5):1441–1450. doi: 10.1093/jnci/59.5.1441. [DOI] [PubMed] [Google Scholar]
  29. Schaller J. P., Mathes L. E., Hoover E. A., Koestner A., Olsen R. G. Increased susceptibility to feline leukemia virus infection in cats exposed to methylnitrosourea. Cancer Res. 1978 Apr;38(4):996–998. [PubMed] [Google Scholar]
  30. Singh V. K., Tingle A. J. Detection of circulating immune complexes by a C1q-microplate ELISA system. J Immunol Methods. 1982;50(1):109–114. doi: 10.1016/0022-1759(82)90308-8. [DOI] [PubMed] [Google Scholar]
  31. Snyder S. P., Dungworth D. L. Pathogenesis of feline viral fibrosarcomas: dose and age effects. J Natl Cancer Inst. 1973 Sep;51(3):793–798. doi: 10.1093/jnci/51.3.793. [DOI] [PubMed] [Google Scholar]
  32. Tuomari D. L., Olsen R. G., Singh V. K., Kraut E. H. Detection of circulating immune complexes by a Clq/protein A-ELISA during the preneoplastic stages of feline leukemia virus infection. Vet Immunol Immunopathol. 1984 Oct;7(3-4):227–238. doi: 10.1016/0165-2427(84)90081-3. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES